Delivery Order SPE2DB20D1100-SPE2DB25FE3J8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,896.35 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a brand-name anticoagulant medication. This non-set-aside, firm fixed price delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical transaction consistent with the...
- The Defense Logistics Agency awarded a $4,929.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,154.40 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed-price contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a standard pharmaceutical supply transaction executed under a non-competitive set-aside. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,405.86 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $13,598.01 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a anticoagulant medication commonly used in military and federal healthcare systems. This non-set-aside, firm fixed price delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,614.63 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, executed on August 25, 2025, with completion scheduled for August 26, 2025, operates under firm fixed pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3J8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,840.26 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This firm fixed price delivery order, effective August 28, 2025, with completion targeted for August 29, 2025, represents a small-value pharmaceutical procurement with no set-aside designation, indicating competitive award to the vendor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs. The DLA Medical Supply Chain utilizes this strategic contracting approach to ensure consistent pharmaceutical availability for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 8/28/25 |